ÂÜÀòÂÒÂ×

Bruce Beutel is the Co-Founder and Chief Executive Officer at Passkey Therapeutics. He is also a Board Member at Enveda Biosciences, Boston Immune Technologies & Therapeutics, GRO Biosciences, and Stellular Bio. Bruce has prior experience as the Chief Strategy and Business Officer at Dewpoint Therapeutics and as the Chief Operating Officer at an unnamed company. Additionally, he has held positions at LS Polaris Innovation Fund, SQZ Biotechnologies, and Merck. Bruce holds a Ph.D. in Molecular Biology from the University of Wisconsin-Madison and a Bachelor's Degree in Biology with Honors from the University of Chicago.